Early detection of subjective cognitive decline and Alzheimer's disease: Analytical validation of a newly developed pT217-tau assay

被引:3
|
作者
Taha, Hash Brown [1 ]
机构
[1] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA
关键词
IMMUNOASSAYS;
D O I
10.1002/alz.13707
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:3112 / 3113
页数:2
相关论文
共 50 条
  • [1] A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease
    Gonzalez-Ortiz, Fernando
    Ferreira, Pamela C. L.
    Gonzalez-Escalante, Armand
    Montoliu-Gaya, Laia
    Ortiz-Romero, Paula
    Kac, Przemyslaw R.
    Turton, Michael
    Kvartsberg, Hlin
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Harrison, Peter
    Bellaver, Bruna
    Povala, Guilherme
    Villemagne, Victor L.
    Pascoal, Tharick A.
    Ganguli, Mary
    Cohen, Anne D.
    Minguillon, Carolina
    Contador, Jose
    Suarez-Calvet, Marc
    Karikari, Thomas K.
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2023,
  • [2] A novel ultrasensitive assay for plasma p-tau217: Performance in individualswith subjective cognitive decline and early Alzheimer's disease
    Gonzalez-Ortiz, Fernando
    Ferreira, Pamela C. L.
    Gonzalez-Escalante, Armand
    Montoliu-Gaya, Laia
    Ortiz-Romero, Paula
    Kac, Przemyslaw R.
    Turton, Michael
    Kvartsberg, Hlin
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Harrison, Peter
    Bellaver, Bruna
    Povala, Guilherme
    Villemagne, Victor L.
    Pascoal, Tharick A.
    Ganguli, Mary
    Cohen, Anne D.
    Minguillon, Carolina
    Contador, Jose
    Suarez-Calvet, Marc
    Karikari, Thomas K.
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2024, 20 (02) : 1239 - 1249
  • [3] Subjective Cognitive Decline in Preclinical Alzheimer's Disease
    Rabin, Laura A.
    Smart, Colette M.
    Amariglio, Rebecca E.
    ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 13, 2017, 13 : 369 - 396
  • [4] Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217
    Gonzalez-Ortiz, Fernando
    Karikari, Thomas K.
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2024,
  • [5] Subjective Cognitive Decline and Biomarkers of Preclinical Alzheimer’s Disease
    Sepideh Shokouhi
    Kimberly Albert
    Current Behavioral Neuroscience Reports, 2019, 6 : 219 - 226
  • [6] Subjective Cognitive Decline and Biomarkers of Preclinical Alzheimer's Disease
    Shokouhi, Sepideh
    Albert, Kimberly
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2019, 6 (04) : 219 - 226
  • [7] Subjective cognitive decline: preclinical manifestation of Alzheimer's disease
    Lin, Yan
    Shan, Pei-Yan
    Jiang, Wen-Jing
    Sheng, Can
    Ma, Lin
    NEUROLOGICAL SCIENCES, 2019, 40 (01) : 41 - 49
  • [8] Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease
    Yan Lin
    Pei-Yan Shan
    Wen-Jing Jiang
    Can Sheng
    Lin Ma
    Neurological Sciences, 2019, 40 : 41 - 49
  • [9] Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217 Reply
    Gonzalez-Ortiz, Fernando
    Karikari, Thomas K.
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 3114 - 3115
  • [10] Psychometric Cognitive Decline Precedes the Advent of Subjective Cognitive Decline in the Evolution of Alzheimer's Disease
    Reisberg, Barry
    Shao, Yongzhao
    Moosavi, Mesum
    Kenowsky, Sunnie
    Vedvyas, Alok
    Marsh, Karyn
    Bao, Jia
    Buj, Maja
    Torossian, Carol
    Kluger, Alan
    Vedvyas, Gaurav
    Oo, Thet
    Malik, Fawad
    Arain, Fauzia
    Masurkar, Arjun, V
    Wisniewski, Thomas
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2020, 49 (01) : 16 - 21